Pataday Once Daily Relief Extra Strength Available Over-the-Counter
Pataday Once Daily Relief Extra Strength is indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.
Ocular Allergy/Inflammation
Eysuvis Now Available For Dry Eye Disease
Eysuvis (loteprednol etabonate ophthalmic suspension) is now available for the short-term treatment of the signs and symptoms of dry eye disease.
Eysuvis Approved for Dry Eye Disease
Results from 4 clinical trials showed that treatment with Eysuvis was associated with significant improvements in both the signs and symptoms of dry eye disease.
Cyclosporine Eyedrops Under Review for Vernal Keratoconjunctivitis
Vernal keratoconjunctivitis is a rare allergic eye disease that affects the pediatric population and results in severe inflammation of the surface of the eye.
Preservative-Free Alaway Gets FDA Approval for OTC Use
The new formulation does not contain benzalkonium chloride.
New Drug Product: Durysta
This slideshow shows drug information for Durysta. Click here for the complete Durysta monograph.
Olopatadine 0.7% Eye Drops Approved for Sale Over-the-Counter
The FDA has approved Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride 0.7%; Alcon) ophthalmic solution, formerly prescribed as Pazeo®, for sale over-the-counter.
Eysuvis Under Review for Dry Eye Disease
The FDA has accepted for review the New Drug Application for Eysuvis™ (loteprednol etabonate ophthalmic suspension; Kala Pharmaceuticals) 0.25% for the treatment of dry eye disease.
Zerviate Ophthalmic Solution Now Available for Allergic Conjunctivitis
Eyevance announced the launch of Zerviate™ (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching associated with allergic conjunctivitis in patients 2 years of age and older.
Tobradex ST Now Available for Inflammatory Eye Conditions With Bacterial Infection
Tobradex ST contains tobramycin, an antibacterial drug, and dexamethasone, a potent corticosteroid.
